Abstract:Abstract Background and Aims At present, the clinical burden and treatment pattern of hyperkalaemia among outpatients in China is not well characterized. The aim of this study was to evaluate the disease distribution and treatment pattern of hyperkalaemia among outpatients in China. Method Data were derived from Beijing Data Center for Rational Use of Drugs, which contains primary records of 157 hospitals, covering 30 provinces in China. Patients who accessed outpatients (aged >=≥18 years old) with record(s) of serum potassium (S-K) between 2015.1.1- 2017.12.31 were included. The laboratory test, diagnoses, and treatments were analyzed. Hyperkalaemia defined as S-K > 5.0 mmol/L. A hyperkalaemia episode was defined as one or more consecutive S-K > 5.0mmol/L measurement(s) within 7 days. If there was a return to S-K <5.0mmol/L within 7 days, the subsequent measurement(s) will be recognized as another hyperkalaemia episode. The proportion of hyperkalaemia was defined as the proportion of patients who experienced at least one hyperkalaemia episode. The main outcomes, including the proportion of hyperkalaemia patients, the diagnosis rate, the treatment rate and the S-K retesting rate were analyzed. The geographic and seasonal distribution of the proportion was examined. The diagnosis rate was defined as the proportion of hyperkalaemia episodes that have diagnoses records of hyperkalaemia within the episode. Treatment rate was defined as the proportion of hyperkalaemia episodes that have records of any hyperkalaemia treatment including diuretics, glucose injection + insulin, calcium injection, sodium bicarbonate, potassium binder, transfer to emergency room or dialysis. Retesting rate was defined as the proportion of hyperkalaemia records that have potassium test record(s) within one day, two days or seven days. Results A total of 2,997,634 patients with at least one S-K record each were analysed. 115,826 patient (3.86%) experienced hyperkalaemia (S-K >5.0mmol/L), in which 28,254 patients (0.94%), experienced S-K ≥5.5mmol/L. In patients with chronic kidney disease, heart failure, hypertension, and diabetes mellitus, the proportions of patients who experienced hyperkalaemia were 22.89%, 12.54%, 7.11% and 6.51%, respectively. Composition proportion of who experienced S-K ≥ 5.5mmol/L, in the patients with CKD and HF, defined as the proportion of patients experienced S-K≥ 5.5mmol/L in all hyperkalaemia patients, were 39.27% and 32.16% respectively, higher than the general population (16.3%). Geographic analysis showed that provinces with higher proportions of hyperkalaemia were Jiangsu (9.22%), Hebei (8.31%), Tianjin (6.74%), Hunan (6.27%) and Liaoning (5.56%). In addition, the seasonal proportion varied as winter (4.18%), autumn (3.93%), spring (3.83%) and summer (3.57%). In patients with hyperkalaemia, the overall hyperkalaemia diagnosed rate within the episode was 2.53%. Diagnosed rates increased by the severity of hyperkalaemia, patients with S-K ≥7.0 mmol/L showed the highest diagnosed rate of 9.63%. The overall hyperkalaemia treated rate was 8.69%. The treated rate of patients with S-K 5.0 to 5.5mmol/L was much lower than that of patients with S-K 5.5 -6.0mmol/L (6.6% vs. 12.01%). The overall retesting rate within 7 days was 11.41%. Patients with S-K 5.0-5.5 mmol/L were retested less frequently (8.51%) than those with S-K ≥5.5 mmol/L (15.56-21.76%). Conclusion The proportions of hyperkalaemia in patients with chronic kidney disease, heart failure, hypertension and diabetes were higher than the proportion in overall outpatients. The severity of hyperkalaemia increased in patients with chronic kidney disease and heart failure. The diagnosed rate, treated rate and resting rate of hyperkalaemia in outpatients were low, showing a slight raise with increased severity.

SAT-186 Extra-potassium Load from Commonly Used Traditional Chinese Medicines Was an Urgent Problem for CKD Patients

Inappropriateness of Medication Prescriptions about Chronic Kidney Disease Patients Without Dialysis Therapy in a Chinese Tertiary Teaching Hospital.

Herbal Medicines for Acute Kidney Injury: Evidence, Gaps and Frontiers

Hyperkalemia burden and treatment patterns in Chinese patients on hemodialysis: final analysis of a prospective multicenter cohort study (PRECEDE-K)

[The Prevalence, Influencing Factors and Prognosis of Abnormal Serum Potassium Levels in Patients with Chronic Kidney Disease].

Hyperkalemia in CKD: an overview of available therapeutic strategies

Efficacy and safety analysis of sodium zirconium cyclosilicate and calcium polystyrene sulfonate on rapid reduction of potassium in moderate to severe hyperkalemia patients with chronic kidney disease without dialysis

Pharmacological potential of Astragali Radix for the treatment of kidney diseases

Tackling Dialysis Burden Around the World: A Global Challenge

Hyperkalemia Incidence in Patients With Non-Dialysis Chronic Kidney Disease: A Large Retrospective Cohort Study From United States Clinical Care

Hyperkalemia Burden and Treatment Pathways in Patients with CKD: Findings From the DISCOVER CKD Retrospective Cohort

Impact of Dietary Potassium Restrictions in CKD on Clinical Outcomes: Benefits of a Plant-Based Diet

Dietary potassium and the kidney: lifesaving physiology

P0799EPIDEMIOLOGY AND TREATMENT PATTERN OF HYPERKALAEMIA AMONG OUTPATIENTS IN CHINA: A DESCRIPTIVE STUDY USING AN ADMINISTRATIVE DATABASE IN CHINA

Clinical Outcomes by Serum Potassium Levels for Patients Hospitalized for Heart Failure: Secondary Analysis of Data from the China National Heart Failure Registry.

A review on the efficacy and mechanism of action of Shenkang injection against chronic kidney disease

Transcending boundaries: Unleashing the potential of multi-organ point-of-care ultrasound in acute kidney injury

Dialysate and serum potassium in hemodialysis

Influence of Co-administered Drugs on Shakuyaku-kanzo-To Induced Hypokalemia

Serum Potassium Levels and Risk of Sudden Cardiac Death Among Patients With Chronic Kidney Disease and Significant Coronary Artery Disease

Hyperkalaemia prevalence and dialysis patterns in Chinese patients on haemodialysis: an interim analysis of a prospective cohort study (PRECEDE-K)